The Wall Street Journal (6/26, Bray) reported that Merck & Co. lost a product-liability suit over whether its osteoporosis drug Fosamax (alendronate) caused osteonecrosis. Bloomberg News (6/25, van Voris, Weidlich) reported, “The jury set damages at $8 million,” which was “$3 million more than the $5 million” sought by the plaintiff’s lawyers. The case is […]
During the COVID-19 emergency we are fully operational and remain available to service all new clients and existing clients, 24/7.
Menu
Directions
Call for Free
E-Mail